⌘K
t
On 9 February 2023, Versarien plc issued an AIM Rule 17 Update correcting its announcement from 7 January 2021. The company stated that Dr Stephen Hodge, Chief Technology Officer, beneficially holds 46,774 ordinary shares of 1 pence each, which were acquired in January 2017 as part of Versarien's acquisition of Cambridge Graphene Limited.
| Date | 9 Feb 2023 |
| Time | 08:33:55 |
| Category | Miscellaneous |
| ID | 4431P |
9 February 2023
Versarien plc
("Versarien" or the "Company")
AIM Rule 17 Update
Versarien plc (AIM: VRS), the advanced materials engineering group, provides the following update in accordance with its disclosure obligations required under Rule 17 of the AIM Rules for Companies.
In a correction to the announcement of 7 January 2021, the Company advises that Dr Stephen Hodge, Chief Technology Officer, holds a beneficial interest in 46,774 ordinary shares of 1 pence each in the Company, acquired as part of Versarien's acquisition of Cambridge Graphene Limited in January 2017.
For further information please contact:
|
Versarien Plc |
|
|
Neill Ricketts - Chief Executive Officer |
+44 (0) 1594 887204 |
|
Chris Leigh - Chief Financial Officer Stephen Hodge - Chief Technology Officer |
|
|
SP Angel Corporate Finance (Nominated Adviser and Joint Broker) |
|
|
Matthew Johnson, Adam Cowl |
+44 (0) 20 3470 0470 |
|
Berenberg (Joint Broker) |
|
|
Mark Whitmore, Ciaran Walsh |
+44 (0) 20 3207 7800 |
|
IFC Advisory Limited (Financial PR and Investor Relations) |
|
|
Tim Metcalfe, Zach Cohen |
+44 (0) 20 3934 6630 |
About Versarien Plc
The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.
For further information please see: https://www.versarien.com